| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.063 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |